What You Should Know: - The digital diabetes market is on track to reach $1.5 billion dollars by 2024, according to a new report by Research2Guidance. - The confident growth of digital diabetes care will be driven by the growth of the global addressable market for digital diabetes services. Between 2019 and 2024, the number of diagnosed diabetics with access to smart devices is set to increase from 109 million to 180 million. - Digital diabetes solutions have disrupted the
Read More
Digital Diabetes Platform
Ascensia Diabetes Care Partners With VisiQuate to Expand Beyond Blood Glucose Monitoring
What You Should Know: - Ascensia Diabetes Care and VisiQuate announced a partnership to expand beyond blood glucose monitoring and provide holistic diabetes management solutions. - The overall solution will provide integration with Ascensia’s existing devices and digital diabetes solutions to enable it to capture data from patients who have consented to provide their information. Ascensia Diabetes Care, a Santa Rosa, CA-based provider of blood glucose monitoring systems
Read More
State of Connecticut Launches of Livongo for Diabetes Management Program through State Health Plan
What You Should Know: - Connecticut state Comptroller Kevin Lembo announces the launch of Livongo for Diabetes Management Program through the state health plan to deliver estimated annual savings to the state of approximately $3 million. - The program, launched in partnership with CVS Caremark and Livongo, is projected to significantly improve health care outcomes for thousands of people with diabetes covered by the state plan by providing them with comprehensive around-the-clock live
Read More
Welldoc, Redox Partner for Bidrectional EHR Integration with BlueStar App
- Welldoc and Redox announce a partnership to ensure bidirectional integration with EHR with Welldoc's digital health solution for diabetes management, BlueStar. - This partnership will allow providers to receive and review insights about users of Welldoc's BlueStar digital health app for diabetes management directly within their EHR at the point of care. Welldoc, a digital health company revolutionizing chronic disease management, announced today its strategic partnership
Read More
BCBS Kansas City to Offer Livongo for Diabetes Program to All Fully Insured Clients
- Livongo announced an expanded partnership with Blue Cross and Blue Shield of Kansas City to provide Livongo for Diabetes program to all Blue KC fully insured clients. - Blue KC was an early Livongo adopter and this expansion provides momentum as we continue to expand from working primarily with self-insured employers to broader markets including fully insured populations of our health plan clients.Livongo Health, Inc. (Nasdaq: LVGO), an Applied Health Signals company empowering people with
Read More
Livongo, VSP Vision Care Partner to Improve Eye Care for People Living with Diabetes
- Livongo announced a partnership with VSP Vision Care to offer mutual Members resources and insights to manage chronic conditions and vision care on one platform. - People with diabetes and prediabetes have an increased risk of vision complications and vision loss and by offering them resources to better manage their eye health on the Livongo platform, we can effectively close gaps in care. Livongo Health, Inc., an Applied Health Signals company empowering people with chronic conditions to live
Read More
Walmart Brings One Drop’s Smart Glucose Meter to Retail Stores Nationwide
- One Drop’s wireless glucose meter kit and supplies for diabetes management are now available at hundreds of Walmart stores in the United States.- Retail expansion increases accessibility of healthcare technology and support for people with chronic conditions such as diabetes and hypertension.One Drop, a New York City-based provider of digital therapeutic solutions for diabetes and other chronic conditions, today announced that its wireless glucose meter kit and supplies are now available at
Read More
Livongo Inks $50M Diabetes Contract Through Federal Employees Health Benefits Program (FEHBP)
- Livongo has been awarded a contract to provide the Livongo for Diabetes solution to eligible members covered by the Federal Employees Health Benefits Program (FEHBP ) under one health plan.- The contract is Livongo’s biggest contract in company history and will account for $20-25M in revenue in 2020 and $30-35M in revenue for 2021, representing a total of $50-60M including both years.- The announcement reflects Livongo’s overall market traction and how they are expanding from working primarily
Read More
FDA Authorizes Interoperable Tandem Insulin Pump for Personalized Diabetes Management
The U.S. Food and Drug Administration (FDA) has permitted marketing of the Tandem Diabetes Care t:Slim X2 insulin pump with interoperable technology (interoperable t:Slim X2) for delivering insulin under the skin for children and adults with diabetes. This new type of insulin pump, Referred to as an alternate controller enabled (ACE) infusion pump, or ACE insulin pump, is the first interoperable insulin pump, meaning it can be used with different components that make up diabetes therapy systems,
Read More
Livongo Acquires Digital Behavioral Health Solution myStrength
Livongo Health, an Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that it has acquired Denver-based myStrength, Inc., a provider of digital behavioral health solutions. Financial terms of the acquisition were not disclosed. The acquisition enables Livongo to more fully address the health of the whole person by integrating behavioral health conditions including depression, anxiety, stress, substance use disorder,
Read More
